Authors' reply to Schaffalitzky de Muckadell and colleague's Comment on 'Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase (TM) between 2014 and 2017'

著录项

• 来源
  《Drug safety: An international journal of medical toxicology and drug experience》 |2019年第5期|共4页
• 作者

  Ehlken Birgit; Nathell Lennart; Gohlke Annegret; Bocuk Derya; Toussi Massoud; Wohlfeil Stefan;

  展开▼
• 作者单位

  IQVIA Landshuter Allee 10 D-80637 Munich Germany;

  Nathell Med AB Vaxthusvagen 6 S-58276 Linkoping Sweden;

  IQVIA Landshuter Allee 10 D-80637 Munich Germany;

  IQVIA Landshuter Allee 10 D-80637 Munich Germany;

  IQVIA 17 Bis Pl Reflets TSA 64567 F-92099 La Defense France;

  Vifor Pharma Management Ltd Flughofstr 61 CH-8152 Glattbrugg Switzerland;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 药品;
• 关键词